SCENESSE® Granted Market Access In Israel
CLINUVEL today announced that SCENESSE® (afamelanotide 16mg) has been added to the...
Read More
Media Release – TGA approves Australian drug to protect patients from light and sun
New Australian-developed drug approved by TGA for metabolic disorder erythropoietic protoporphyria (EPP)...
Read More
Australian TGA approves SCENESSE®
Executive summary SCENESSE® approved by Australian TGA under Priority Review First approved...
Read More